Home Transplant Genomics

Transplant Genomics

acquired
-
Biotechnology Company

Basic Information

Transplant Genomics is a biotechnology company focused on improving organ transplant outcomes through genomics-guided non-invasive continuous monitoring. Its extensive development pipeline includes diagnostic and predictive tests for renal and hepatic graft dysfunction, the use of multiple sample types and technology platforms, companion diagnostics for immunosuppressants, and immune status testing.
Transplant Genomics Inc.
Massachusetts,United States of America
less than 15 people
January 01, 2013
info@transplantgenomics.com